Enthusiasm and Ethics

Emmanuelle Charpentier and Jennifer Doudna's interest in CRISPR stemmed from its role as a sort of bacterial immune system, but along the way, they realized that CRISPR and its enabling protein Cas9 could be combined into a single tool that could possibly work in a range of organisms, the New York Times Magazine reports.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.